Affordable Access

deepdyve-link
Publisher Website

Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

Authors
  • Alhussien, Ahmed H1
  • Alhedaithy, Riyadh A2
  • Alsaleh, Saad A3
  • 1 College of Medicine, King Saud University, Riyadh, Saudi Arabia. , (Saudi Arabia)
  • 2 Division of Otolaryngology, Head and Neck Surgery, Department of Surgery, King Abdulaziz Medical City, National Guard Health Affairs, P.O. Box 22490, Riyadh, 11426, Saudi Arabia. [email protected] , (Saudi Arabia)
  • 3 Rhinology and Endoscopic Skull Base Surgery Unit, Otolaryngology, Head and Neck Surgery Department, King Saud University Medical City, Riyadh, Saudi Arabia. , (Saudi Arabia)
Type
Published Article
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Publication Date
Feb 01, 2018
Volume
275
Issue
2
Pages
325–333
Identifiers
DOI: 10.1007/s00405-017-4785-3
PMID: 29164323
Source
Medline
Keywords
License
Unknown

Abstract

Lacking sufficient clinical trials on the use of intranasal corticosteroid sprays in pregnancy, we suggest that the intranasal use of fluticasone furoate, mometasone, and budesonide is safe if they are used at the recommended therapeutic dose after a proper medical evaluation. Intranasal fluticasone propionate might be a safe option in the absence of other INCS options due to its questionable efficacy during pregnancy. Risk-benefit ratio should always be considered before prescribing any intranasal corticosteroid sprays during pregnancy.

Report this publication

Statistics

Seen <100 times